Preventive effect of bariatric surgery on type 2 diabetes onset in morbidly obese inpatients: a national French survey between 2008 and 2016 on 328 509 morbidly obese

Recently, bariatric surgery (BS) has been shown to be effective against type 2 diabetes (T2D) in patients with obesity, improving glycemic control, quality of life, and reducing cardiovascular risk, compared to patients not undergoing BS[1,2]. In recent years a sharp increase in the number of bariatric procedures has been observed worldwide.[3] The most commonly performed bariatric procedures in France and in other countries are the adjustable gastric band (AGB), sleeve gastrectomy (SG), which are both considered restrictive procedures, and the gastric bypass (GB).
Source: Surgery for Obesity and Related Diseases - Category: Surgery Authors: Source Type: research